- Home
- EVO vs DEA Comparison
EVO vs DEA Comparison
Compare EVO & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- DEA
- Stock Information
- Founded
- EVO 1993
- DEA 2011
- Country
- EVO Germany
- DEA United States
- Employees
- EVO N/A
- DEA N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- DEA Real Estate Investment Trusts
- Sector
- EVO Health Care
- DEA Real Estate
- Exchange
- EVO Nasdaq
- DEA Nasdaq
- Market Cap
- EVO 1.2B
- DEA 1.0B
- IPO Year
- EVO 2021
- DEA 2015
- Fundamental
- Price
- EVO $3.48
- DEA $23.31
- Analyst Decision
- EVO Buy
- DEA Hold
- Analyst Count
- EVO 2
- DEA 5
- Target Price
- EVO $5.40
- DEA $27.15
- AVG Volume (30 Days)
- EVO 52.1K
- DEA 574.1K
- Earning Date
- EVO 11-05-2025
- DEA 11-04-2025
- Dividend Yield
- EVO N/A
- DEA 7.76%
- EPS Growth
- EVO N/A
- DEA N/A
- EPS
- EVO N/A
- DEA 0.38
- Revenue
- EVO $912,894,891.00
- DEA $322,861,000.00
- Revenue This Year
- EVO $0.43
- DEA $8.78
- Revenue Next Year
- EVO $9.72
- DEA $6.43
- P/E Ratio
- EVO N/A
- DEA $61.42
- Revenue Growth
- EVO N/A
- DEA 7.93
- 52 Week Low
- EVO $2.84
- DEA $19.33
- 52 Week High
- EVO $5.64
- DEA $36.31
- Technical
- Relative Strength Index (RSI)
- EVO 39.62
- DEA 61.76
- Support Level
- EVO $3.36
- DEA $22.40
- Resistance Level
- EVO $3.52
- DEA $23.32
- Average True Range (ATR)
- EVO 0.08
- DEA 0.52
- MACD
- EVO 0.00
- DEA 0.10
- Stochastic Oscillator
- EVO 31.58
- DEA 99.60
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.